EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nucleocapsid Protein of SARS-CoV-2 Upregulates RANTES Expression in A172 Glioblastoma Cells

Bakhytgul Gadilgereyeva iD, Zhanar Kunushpayeva, Mira Abdrakhmanova, Aizere Khassenova, Nail Minigulov, Timo Burster iD, Olena Filchakova iD

Molecules · 2025

DOI: 10.3390/molecules30051066 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Bakhytgul Gadilgereyeva und 6 weiteren Autor:innen. Beteiligte Einrichtung: Biology Department, School of Sciences and Humanities, Nazarbayev University, Kabanbay Batyr ave., 53, Astana 010000, Kazakhstan. Hauptthemen laut MEDLINE: Glioblastoma, SARS-CoV-2, Chemokine CCL5, Coronavirus Nucleocapsid Proteins. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FDA HHS, Nazarbayev University, Nazarbayev University (NU) Faculty Development Competitive Research Grant (FDCRGP).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SARS-CoV-2, the pathogenic virus that induces COVID-19 disease, contains four structural proteins in its virion. The nucleocapsid (N) protein is one of the four structural proteins that play a crucial role in the assembly of viral RNA into ribonucleoprotein. In addition, the N protein contributes to viral pathogenesis. One of the functions attributed to the N protein is the triggering of cytokine release by lung epithelial cells, macrophages, and monocytes. This study addresses the cellular effects of the N protein of SARS-CoV-2 on cells of glial origin. We report the upregulation of the RANTES chemokine in A172 glioblastoma cells at both the mRNA and protein levels in response to exposure to SARS-CoV-2 nucleocapsid protein. The N protein did not have an effect on cell viability and cell migration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaSARS-CoV-2Chemokine CCL5Coronavirus Nucleocapsid ProteinsHumansUp-RegulationCell Line, TumorCOVID-19Cell MovementCell SurvivalPhosphoproteins

Stichwörter der Autor:innen

RANTESSARS-CoV-2coronavirusesglioblastomanucleocapsid protein

Substanzen

Chemokine CCL5Coronavirus Nucleocapsid Proteinsnucleocapsid phosphoprotein, SARS-CoV-2CCL5 protein, humanPhosphoproteins

Autor:innen und Institutionen

  • Biology Department, School of Sciences and Humanities, Nazarbayev University, Kabanbay Batyr ave., 53, Astana 010000, Kazakhstan.

ORCID-Profile: Bakhytgul Gadilgereyeva, Timo Burster, Olena Filchakova

Förderung

  • FDA HHS
  • Nazarbayev University
  • Nazarbayev University (NU) Faculty Development Competitive Research Grant (FDCRGP)
  • Nazarbayev University (NU) Collaborative Research Grant (CRP)

Zitieren

APA

Gadilgereyeva, B., Kunushpayeva, Z., Abdrakhmanova, M., Khassenova, A., Minigulov, N., Burster, T., & Filchakova, O. (2025). Nucleocapsid Protein of SARS-CoV-2 Upregulates RANTES Expression in A172 Glioblastoma Cells. Molecules. https://doi.org/10.3390/molecules30051066

Vancouver

Gadilgereyeva B, Kunushpayeva Z, Abdrakhmanova M, Khassenova A, Minigulov N, Burster T, et al. Nucleocapsid Protein of SARS-CoV-2 Upregulates RANTES Expression in A172 Glioblastoma Cells. Molecules. 2025. doi:10.3390/molecules30051066

BibTeX
@article{Gadilgereyeva2025,
  author = {Gadilgereyeva, Bakhytgul and Kunushpayeva, Zhanar and Abdrakhmanova, Mira and Khassenova, Aizere and Minigulov, Nail and Burster, Timo and Filchakova, Olena},
  title = {Nucleocapsid Protein of SARS-CoV-2 Upregulates RANTES Expression in A172 Glioblastoma Cells},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30051066}
}
Kostenlos starten →